Cian Healthcare (BOM:542678) Payments of Debt: ₹-276.5 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:542678 Cian Healthcare Ltd BOM:542678
45 GF Score
Price ₹15.48
GF Value ₹8.27
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Cian Healthcare Payments of Debt?

Cian Healthcare BOM:542678 +4.95% 45 Payments of Debt is ₹-276.5 Mil as of Mar. 2026. GuruFocus rates BOM:542678 with a GF Score™ of 45/100 and a GF Value™ of ₹8.27 (Significantly Overvalued). The stock has 6 warning signs investors should review.

Cian Healthcare's Payments of Debt for the six months ended in Mar. 2026 was ₹-276.5 Mil.

Cian Healthcare's Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 was ₹-276.5 Mil.

Cian Healthcare Payments of Debt Related Terms

Cian Healthcare Payments of Debt Historical Data

* Premium members only.

The historical data trend for Cian Healthcare's Payments of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cian Healthcare Payments of Debt Chart

Cian Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Payments of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only -81.73 -87.48 -51.24 -206.38 -276.50

Cian Healthcare Semi-Annual Data
Mar16 Mar17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Payments of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -24.15 -46.35 0.00 -0.04 -276.46
BOM:542678
45GF Score
Cian Healthcare Ltd BOM:542678
Payments of Debt is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cian Healthcare Payments of Debt Calculation

Payments of Debt represents all the cash outflow from debt, including both long-term debt and short-term debt.

Payments of Debt for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was ₹-276.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Payments of Debt →
What does a Payments of Debt of ₹-276.5 Mil mean?
Cian Healthcare (BOM:542678) has a Payments of Debt of ₹-276.5 Mil as of Mar. 2026. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Cian Healthcare and its competitors.
Is Cian Healthcare's Payments of Debt too high?
Cian Healthcare's current Payments of Debt is ₹-276.5 Mil. Overall, Cian Healthcare has a GF Score™ of 45/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Cian Healthcare's Payments of Debt compare to ZTS and UTHR?
Cian Healthcare's Payments of Debt of ₹-276.5 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Payments of Debt for a Drug Manufacturers company?
A good Payments of Debt depends on the Drug Manufacturers industry context. However, Payments of Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Payments of Debt mean?
A high Payments of Debt can signal that a stock is expensive relative to its fundamentals. Payments of Debt is all the cash outflow from debt, including both long-term debt and short-term debt. View historical data on Cian Healthcare and its competitors. Cian Healthcare's current Payments of Debt is ₹-276.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cian Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Cian Healthcare (BOM:542678) is currently considered Significantly Overvalued. The stock's GF Value™ is ₹8.27, compared to a current price of ₹15.48 — trading 87.2% above its estimated fair value. The current Payments of Debt is ₹-276.5 Mil. Cian Healthcare's overall GF Score™ is 45/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Payments of Debt calculated?
Payments of Debt is calculated from a company's financial statements. For Cian Healthcare (BOM:542678), the current Payments of Debt is ₹-276.5 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Cian Healthcare (BOM:542678) Overvalued in 2026?

Based on GuruFocus' analysis, Cian Healthcare stock appears to be overvalued. The current stock price of ₹15.48 is trading 87.2% above its estimated GF Value™ of ₹8.27. GuruFocus considers Cian Healthcare to be Significantly Overvalued.

Key valuation signals for BOM:542678:

  • Payments of Debt: ₹-276.5 Mil
  • GF Value™: ₹8.27 vs. price of ₹15.48 (87.2% above fair value)
  • GF Score™: 45/100 with 6 warning signs

No single metric tells the full story. See the BOM:542678 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Cian Healthcare Business Description

Address Mundhwa Kharadi Road, Kirtane Baugh, Office No 301 Konark Icon 3rd Floor, Magarpatta Hadapsar, Mundhwa, Pune, MH, IND, 411036
Cian Healthcare Ltd is a fully integrated pharmaceutical company engaged in the research, development, manufacturing, and marketing of pharmaceutical products. The company manufactures multiple product lines, including tablets, capsules, soft gels, liquid orals, ointments/creams and sachets, and cosmetics. Its portfolio comprises gynecology, haematinic, cardio-diabetic, orthopedic, pediatric, dermacosmetic, antibiotic, CNS, vitamins, and nutrient products. The company operates in five sectors: Export, Government Supplies, Merchant Export, Own Brand Franchise Business, and Third Party/Contract Manufacturing.
45GF Score

Get the complete analysis for BOM:542678

Payments of Debt is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹15.48
Price
₹8.27
GF Value